HLTH USA: AI Configured on Clinical Guidelines to Find More Untreated Cachectic Cancer Patients

JAMIA Publication:The Potential and Pitfalls of using a LLM as a Clinical Assistant

Full Steam Ahead: How AI Can Transform the Genetics Journey in Precision Medicine

Pangaea Data Awarded Top Tier Co-Sell Partnership Status by Microsoft

WHITEPAPER: How can Pharma & Healthcare Collaborate in a Financially Sustainable & Scalable Manner?

GO BACK

Pangaea Presenting at 5th Annual McKinsey Cancer Center Symposium

10:00AM - 11:30AM CET, October 20th 2023, Madrid, Spain & Virtual

Venue: Novotel Madrid Campo de las Naciones, Madrid, Spain

Session: Oncology Rewired – Improving Patient Lives with Digital Health

Discover how the UK’s NHS applied Pangaea’s product to find 6x more undiagnosed and miscoded cachectic cancer patients compared to natural language processing (NLP) approaches. This led to improved resource optimization and halved treatment costs, saving £1 billion annually. Additionally, this benefited pharmaceutical sponsors by expanding the pool of potentially suitable patients for their trials and therapies six-fold while preserving patient privacy. Pangaea has demonstrated success across oncology conditions, such discovering more lung and ovarian cancer patients suitable for screening, and fosters financially sustainable and scalable collaboration between both industries, revolutionizing patient care.

Please register here to join the panel discussion.


Register to Meet Us

Presenter

Dr. Vibhor Gupta
Director & Founder
Pangaea Data